347 related articles for article (PubMed ID: 27191854)
1. Fibrin clot formation and fibrinolysis in patients with a history of coronary stent thrombosis.
Godschalk TC; Konings J; Govers-Riemslag JW; Ten Berg JM; Hackeng CM; Ten Cate H
Thromb Res; 2016 Jul; 143():58-62. PubMed ID: 27191854
[TBL] [Abstract][Full Text] [Related]
2. Altered plasma fibrin clot properties are associated with in-stent thrombosis.
Undas A; Zalewski J; Krochin M; Siudak Z; Sadowski M; Pregowski J; Dudek D; Janion M; Witkowski A; Zmudka K
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):276-82. PubMed ID: 19910643
[TBL] [Abstract][Full Text] [Related]
3. Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.
Mastalerz L; Celińska-Lӧwenhoff M; Krawiec P; Batko B; Tłustochowicz W; Undas A
PLoS One; 2015; 10(11):e0142167. PubMed ID: 26540111
[TBL] [Abstract][Full Text] [Related]
4. Increased von Willebrand factor, P-selectin and fibrin content in occlusive thrombus resistant to lytic therapy.
Sambola A; García Del Blanco B; Ruiz-Meana M; Francisco J; Barrabés JA; Figueras J; Bañeras J; Otaegui I; Rojas A; Vilardosa Ú; Montaner J; García-Dorado D
Thromb Haemost; 2016 Jun; 115(6):1129-37. PubMed ID: 26962963
[TBL] [Abstract][Full Text] [Related]
5. Altered plasma fibrin clot properties in essential thrombocythemia.
Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
[TBL] [Abstract][Full Text] [Related]
6. A history of early stent thrombosis is associated with prolonged clot lysis time.
Pankiw-Bembenek O; Zalewski J; Goralczyk T; Undas A
Thromb Haemost; 2012 Mar; 107(3):513-20. PubMed ID: 22274545
[TBL] [Abstract][Full Text] [Related]
7. Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.
Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Podolak-Dawidziak M; Kuliczkowski K
Eur J Clin Invest; 2014 Jun; 44(6):557-66. PubMed ID: 24738991
[TBL] [Abstract][Full Text] [Related]
8. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
Undas A; Kolarz M; Kopeć G; Tracz W
Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458
[TBL] [Abstract][Full Text] [Related]
9. Altered plasma fibrin clot properties in hypertensive patients with obstructive sleep apnoea are improved by continuous positive airway pressure treatment.
Jóźwik-Plebanek K; Prejbisz A; Wypasek E; Pręgowska-Chwała B; Hanus K; Kaszuba AM; Januszewicz M; Bieleń P; Kabat M; Kruk M; Dobrowolski P; Klisiewicz A; Śliwiński P; Januszewicz A; Undas A
J Hypertens; 2017 May; 35(5):1035-1043. PubMed ID: 28141659
[TBL] [Abstract][Full Text] [Related]
10. Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation.
Gronostaj K; Richter P; Nowak W; Undas A
Thromb Res; 2013 Mar; 131(3):262-7. PubMed ID: 23273404
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
Szczepaniak P; Zabczyk M; Undas A
PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
[TBL] [Abstract][Full Text] [Related]
12. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
Konieczynska M; Fil K; Bazanek M; Undas A
Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
[TBL] [Abstract][Full Text] [Related]
13. No-reflow phenomenon after acute myocardial infarction is associated with reduced clot permeability and susceptibility to lysis.
Zalewski J; Undas A; Godlewski J; Stepien E; Zmudka K
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2258-65. PubMed ID: 17673704
[TBL] [Abstract][Full Text] [Related]
14. The hypercoagulable profile of patients with stent thrombosis.
Loeffen R; Godschalk TC; van Oerle R; Spronk HM; Hackeng CM; ten Berg JM; ten Cate H
Heart; 2015 Jul; 101(14):1126-32. PubMed ID: 25999588
[TBL] [Abstract][Full Text] [Related]
15. Prothrombotic alterations in plasma fibrin clot properties in thyroid disorders and their post-treatment modifications.
Mazur P; Sokołowski G; Hubalewska-Dydejczyk A; Płaczkiewicz-Jankowska E; Undas A
Thromb Res; 2014 Aug; 134(2):510-7. PubMed ID: 24962680
[TBL] [Abstract][Full Text] [Related]
16. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
Kwasny-Krochin B; Gluszko P; Undas A
Thromb Res; 2010 Jul; 126(1):e11-6. PubMed ID: 20471669
[TBL] [Abstract][Full Text] [Related]
17. Altered Fibrin Clot Properties in Patients With Cerebral Venous Sinus Thrombosis: Association With the Risk of Recurrence.
Siudut J; Świat M; Undas A
Stroke; 2015 Sep; 46(9):2665-8. PubMed ID: 26173730
[TBL] [Abstract][Full Text] [Related]
18. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
Drabik L; Wołkow P; Undas A
Thromb Res; 2015 Aug; 136(2):408-14. PubMed ID: 26048399
[TBL] [Abstract][Full Text] [Related]
19. Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception.
Piróg M; Piwowarczyk S; Undas A
Dis Markers; 2019; 2019():4923535. PubMed ID: 31827635
[TBL] [Abstract][Full Text] [Related]
20. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]